Basel, Switzerland

Oliver Geiseler


 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Oliver Geiseler

Introduction

Oliver Geiseler is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of chemistry, particularly in the synthesis of pharmaceutical compounds. His work has implications for the production of important medications, showcasing his expertise and innovative spirit.

Latest Patents

Oliver Geiseler holds a patent for the "Synthesis of noroxymorphone." This invention relates to an improved method for synthesizing noroxymorphone, which is crucial in the pharmaceutical industry. The patent outlines a process that effectively reduces impurity levels in the final product while avoiding lengthy purification steps. This advancement not only enhances the quality of the product but also streamlines the manufacturing process.

Career Highlights

Geiseler is associated with Siegfried Aktiengesellschaft, a prominent company in the pharmaceutical sector. His role at the company allows him to apply his innovative ideas and contribute to the development of new and improved pharmaceutical products. His work is characterized by a commitment to excellence and a focus on practical solutions to complex problems.

Collaborations

Throughout his career, Oliver has collaborated with esteemed colleagues such as Ernesto Santandrea and Beat Theodor Weber. These partnerships have fostered a creative environment that encourages the exchange of ideas and the pursuit of groundbreaking innovations.

Conclusion

Oliver Geiseler's contributions to the field of chemistry and pharmaceuticals exemplify the impact of innovation in improving product quality and manufacturing efficiency. His work continues to influence the industry, paving the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…